FDA Authorizes Pfizer and Moderna Boosters for 18+

This morning, the FDA expanded eligibility around booster shots of both the Pfizer and Moderna vaccines for adults 18+, six months after their primary series. Those who have received a Johnson & Johnson vaccine for their primary series can receive a Pfizer or Moderna booster dose two months after their single dose primary series

Read More »

CDC Amends EUA to Include 4th Dose for Immunocompromised

Yesterday, the CDC updated their guidelines on COVID-19 vaccines for those who are “moderately and severely” immunocompromised. People who fall into this category include those living with autoimmune disease, who are currently on therapies such as high-dose corticosteroids and other drugs that suppress the immune system.

Read More »

CDC Endorses Boosters for Moderna and J&J Vaccines

Last night, the CDC endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation in favor of booster doses for the Moderna and Johnson & Johnson (J&J) vaccines. The Moderna vaccine has been endorsed for use as a booster vaccine (at least 6 months after the primary series) in the following populations:

Read More »

FDA Authorizes Use of J&J and Moderna Boosters, as well as Mix-and-Matching

Last night, the FDA issued a news release on the use of the Moderna and Johnson & Johnson (J&J) vaccines, including implementation of the mix-and-match method for boosters. The agency amended the emergency use authorization (EUA) for COVID-19 vaccines to allow for booster doses, adding that, “the use of a single booster dose of the Moderna COVID-19 Vaccine that may be administered at least 6 months after completion of the primary series” to individuals:

Read More »
Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.